<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report on 2 children with Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> accompanied by extensive extranodal involvement treated with chemotherapy and Rituximab in combination with autologous peripheral blood stem cell transplantation (Auto-PBSCT) regimens </plain></SENT>
<SENT sid="1" pm="."><plain>No obvious side effects could be seen during the Rituximab therapy </plain></SENT>
<SENT sid="2" pm="."><plain>Both children achieved complete remission with no relapse after being followed up for 4.3 and 4 years, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>Our limited experience show that Rituximab in combination with chemotherapy and Auto-PBSCT might have better therapeutic effects on Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of children and the side effects of Rituximab therapy is minimal and can be well tolerated </plain></SENT>
</text></document>